StockData
Apyx Medical Corp logo

Apyx Medical Corp (APYX) stock

APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3031% above fair value
$2.65−0.16 (-5.69%)

Close on Nov 16, 2026Market cap $111.63MP/E –Yield –

Apyx Medical revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Apyx Medical's revenue for the twelve months ending Sep 30, 2026 was $59.57M, up 24.4% year over year. For fiscal 2025 it was $52.84M, up 9.9% from the year before. Over ten years it grew 6.0% a year on average. The highest annual figure on record is $52.84M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$52.84M+9.9%
FY2024Dec 31, 2024$48.10M-8.1%
FY2023Dec 31, 2023$52.35M+17.6%
FY2022Dec 31, 2022$44.51M-8.3%
FY2021Dec 31, 2021$48.52M+75.1%
FY2020Dec 31, 2020$27.71M-1.9%
FY2019Dec 31, 2019$28.24M+70.0%
FY2018Dec 31, 2018$16.61M+62.3%
FY2017Dec 31, 2017$10.23M+16.0%
FY2016Dec 31, 2016$8.82M-70.1%
FY2015Dec 31, 2015$29.52M+6.6%
FY2014Dec 31, 2014$27.68M+17.0%
FY2013Dec 31, 2013$23.66M-14.5%
FY2012Dec 31, 2012$27.67M+8.9%
FY2011Dec 31, 2011$25.41M+4.9%
FY2010Dec 31, 2010$24.23M-10.1%
FY2009Dec 31, 2009$26.95M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$14.03M+9.0%
Q2 FY2026Jun 30, 2026$13.88M+22.1%
Q1 FY2026Mar 31, 2026$12.49M+32.4%
Q4 FY2025Dec 31, 2025$19.16M+34.7%
Q3 FY2025Sep 30, 2025$12.88M+12.1%
Q2 FY2025Jun 30, 2025$11.37M-6.4%
Q1 FY2025Mar 31, 2025$9.43M-7.9%
Q4 FY2024Dec 31, 2024$14.22M-3.0%
Q3 FY2024Sep 30, 2024$11.49M-4.1%
Q2 FY2024Jun 30, 2024$12.15M-10.5%
Q1 FY2024Mar 31, 2024$10.24M-15.6%
Q4 FY2023Dec 31, 2023$14.66M+16.3%
Q3 FY2023Sep 30, 2023$11.98M+31.4%
Q2 FY2023Jun 30, 2023$13.57M+31.8%
Q1 FY2023Mar 31, 2023$12.14M-2.8%
Q4 FY2022Dec 31, 2022$12.61M-25.0%
Q3 FY2022Sep 30, 2022$9.11M-23.0%
Q2 FY2022Jun 30, 2022$10.29M-8.3%
Q1 FY2022Mar 31, 2022$12.49M+44.6%
Q4 FY2021Dec 31, 2021$16.82M+46.8%
Q3 FY2021Sep 30, 2021$11.83M+70.1%
Q2 FY2021Jun 30, 2021$11.22M+161.3%
Q1 FY2021Mar 31, 2021$8.64M+72.9%
Q4 FY2020Dec 31, 2020$11.46M+36.8%
Q3 FY2020Sep 30, 2020$6.95M-8.2%
Q2 FY2020Jun 30, 2020$4.30M-35.4%
Q1 FY2020Mar 31, 2020$5.00M-11.2%
Q4 FY2019Dec 31, 2019$8.38M+43.4%
Q3 FY2019Sep 30, 2019$7.58M+106.3%
Q2 FY2019Jun 30, 2019$6.65M+80.1%
Q1 FY2019Mar 31, 2019$5.63M+65.7%
Q4 FY2018Dec 31, 2018$5.85M+59.8%
Q3 FY2018Sep 30, 2018$3.67M+38.5%
Q2 FY2018Jun 30, 2018$3.69M+59.7%
Q1 FY2018Mar 31, 2018$3.40M+110.5%
Q4 FY2017Dec 31, 2017$3.66M-61.5%
Q3 FY2017Sep 30, 2017$2.65M–
Q2 FY2017Jun 30, 2017$2.31M–
Q1 FY2017Mar 31, 2017$1.61M–
Q4 FY2016Dec 31, 2016$9.49M–

More Apyx Medical figures

See a number that looks wrong?